바이오스펙테이터

Tomocube, Insights From the Customer 'Holotomography 2.0'

토모큐브, “고객서 다시 출발” 신제품 '의미·확장성'은

Standigm has 'evidence-based' AI-aided drug target discovery platform.."global competitiveness"

Veraverse, What is the concept of 'Bioenergetic Checkpoint Inhibition'?

팜캐드, '양자+AI' 기반 신약개발.."RNA·TPD 도전"

노벨티노빌리티, 글리벡 내성 종양 ‘c-KIT ADC’ “내년 임상”

듀셀바이오, ‘공급부족’ 혈소판 개발 '3가지 포인트'

베라버스, 대사항암제 개발 '에너지관문 억제' 컨셉은?

엠디바이오랩, 新타깃 'TG2 저해제' 전임상 "첫 공개"

Seers Technology has the strength in the field of 'Untact Care' based on the 'Wearable'

Medinno’s strategy with ‘pre-conditioned stem cell’ for neonatal neurological disorders

메디노, 신생아 신경질환 '프라이밍 줄기세포' 전략은?

AbTis, Three Differentiable Points of the Next-Generation ADC Platform

스탠다임, '해석가능' 타깃발굴 AI "글로벌 경쟁력"

‘Turning point’ of ABL, T cell engager is “the reason to be confident”